Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 28 for your search:
Cancer Type/Condition:  Prostate cancer
Trial Type:  Prevention
Trial Status:  Closed
Sponsor of Trial:  NCI
Start Over
        Show
1.

Phase: Phase III
Type: Prevention, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-98014, NCI-G98-1445, NCT00003367

2.

Phase: Phase III
Type: Prevention
Status: Closed
Age: 55 and over (50 and over for African Americans)
Sponsor: NCI, Other
Protocol IDs: CDR0000068277, S0000, U10CA037429, SWOG-S0000, CAN-NCIC-S0000, CALGB-S0000, ECOG-S0000, NCCAM, NCI-P00-0172, NCT00006392

3.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 50 to 80
Sponsor: NCI
Protocol IDs: MCC-0002, NCI-4031, NCI-P01-0195, NCT00027950

4.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 40 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069210, U10CA037429, S9917, CALGB-70004, NCI-P02-0203, SWOG-S9917, ECOG-SWOG-S9917, NCT00030901

5.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 55 and over
Sponsor: NCI
Protocol IDs: SWOG-9217, PCPT-1, NCI-P93-0049

6.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: Under 80
Sponsor: NCI, Other
Protocol IDs: 01-0506-01, R01CA077789, P30CA023074, UARIZ-99-0045-01,, 99-0045-01, NCT00978718

7.

Phase: Phase II
Type: Prevention
Status: Completed
Age: Over 18
Sponsor: NCI
Protocol IDs: UAB-9431, NCI-P97-0103

8.

Phase: Phase II
Type: Prevention
Status: Closed
Age: 40 to 75
Sponsor: NCI
Protocol IDs: BCM-H2533, NCI-P97-0107

9.

Phase: Phase II
Type: Prevention
Status: Closed
Age: 35 to 70
Sponsor: NCI, Other
Protocol IDs: CDR0000068110, UCIRVINE-97-18, UCIRVINE-U01-CA-81886-01, NCI-P00-0164, NCT00006101

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention, Treatment
Status: Completed
Age: Over 18
Sponsor: NCI
Protocol IDs: PCI-00-105, CDR0000068708, PCI-N01-CN-75018, NCI-P01-0181, NCT00020735

11.

Phase: Phase II
Type: Prevention, Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: SWOG-S9812, NCI-P01-0182

12.

Phase: Phase II
Type: Prevention
Status: Closed
Age: 40 to 80
Sponsor: NCI
Protocol IDs: UCLA-0001030, NCI-G01-1973, NCT00020995

13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000353197, P30CA022453, WSU-C-2418, NCT00078923

14.

Phase: Phase II
Type: Prevention
Status: Closed
Age: 30 to 80
Sponsor: NCI, Other
Protocol IDs: MCC-15008, R01 CA12060-01A1, NCT00596011

15.

Phase: Phase II
Type: Prevention, Treatment
Status: Closed
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068813, P30CA014520, WCCC-CO-99802, NCI-N01-CN-95130, WCCC-CO-2000169, NCI-P01-0188, NCT00022412

16.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00451, UWI09-14-01, CDR0000698228, CO-10805, N01CN35153, P30CA014520, NCT01325311

17.

Phase: Phase I
Type: Prevention, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-98-C-0099B

18.

Phase: Phase I
Type: Prevention
Status: Completed
Age: 18 to 45
Sponsor: NCI
Protocol IDs: UIC-H-99-058, UIC-N01-CN-85081, NCI-P00-0143, NCT00006078

19.

Phase: Phase I
Type: Prevention
Status: Completed
Age: 18 to 45
Sponsor: NCI
Protocol IDs: UIC-2004-0040, N01-CN-85081-3, NCT00093561

20.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 35 to 75
Sponsor: NCI
Protocol IDs: UIC-2000-0931, NCT00416325

21.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: 18 to 55
Sponsor: NCI
Protocol IDs: NCI-2012-02709, UIC-2006-0853, CDR0000536181, N01CN85081, N01-CN85081-4, NCT00450957

22.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 120802, P30CA072720, CDR0000639070, CINJ-120802, NCT00895115

23.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 40 to 80
Sponsor: NCI
Protocol IDs: NCI-2012-00085, CDR0000717828, I 182210, NWU09-4-03, P30CA060553, N01CN35157, NU-NWU09-4-03, NCT01497431

24.

Phase: No phase specified
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067929, NCCTG-959257, MAYO-959257, MAYO-IRB-921-97, NCI-P00-0156, NCT00006214

25.

Phase: No phase specified
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000443617, P30CA069533, OHSU-CI-CPC-04131-LX, VAMC-04-0303/ M1016, DOD-W81XWH-04-1-0296, OHSU-1117, KPNW-NW-05SLIEB-01, VAMC-04-0303, DOD-A-12538, OHSU-KPNW-NW-05SLIEB-01, NCT00253643
1   
New Search